| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Officer Level 14 | EVP &Chief Scientific Officer +2 more
1 company
Bennett C Frank is an EVP, Chief Scientific Officer at IONS. Recent filings cover 0 purchases and 23 sales. Those positions are worth an estimated $3.1M at current prices.
Our model assigns Bennett C Frank a middling insider score of 64/100, based on 15 past trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of -8.4%.
Bennett C Frank's largest disclosed position is in IONS as EVP, Chief Scientific Officer, worth about $3.1M. The recent filings there lean toward selling, a net 210,496 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | IONS Ionis Pharmaceuticals, Inc. | EVP, Chief Scientific Officer | Sell | 20,536 | $84.95 | $1,744,623.34 | -100% | - | - | |
| Jan 30, 2026 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sell | 5,885 | $82.95 | $488,140.74 | -5.5% | -9.6% | - | |
| Sep 5, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sell | 6,000 | $59.60 | $357,580.80 | -6.8% | +33.6% | - | |
| Sep 3, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sale+OE | 38,909 | $59.14 | $2,301,263.58 | -27.7% | +34.4% | - | |
| Aug 18, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sale+OE | 10,000 | $43.98 | $439,776.00 | -9.7% | +68.7% | - | |
| Jan 31, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sell | 1,327 | $32.46 | $43,079.20 | -1.4% | -0.6% | +159.2% | |
| Jan 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sale+OE | 6,752 | $32.90 | $222,113.79 | -6.9% | -12.2% | +136.5% | |
| Feb 2, 2024 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sell | 1,853 | $49.52 | $91,752.41 | -2.3% | -13.4% | -35.9% | |
| Jan 17, 2024 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sale+OE | 6,745 | $50.42 | $340,062.67 | -8.0% | -19.0% | -37.1% | |
| Dec 21, 2023 | IONS Ionis Pharmaceuticals Inc | EVP, Chief Scientific Officer | Sale+OE | 22,613 | $49.39 | $1,116,854.48 | -25.6% | -12.9% | -27.4% |